ArticleAmerican journal of translational research2021

SGLT-2 inhibitor intervention in diabetes mellitus patients can reduce the incidence of renal injury and adverse events.

Xiaoyan Tao et al.PubMed ↗Full text ↗

No numbers read from the abstract.